PAULINA CROUSE: Open Payments
NPI 1225702012 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,620 in 198 payments from 24 companies in 2025. Trend: 2023 $3,593 · 2024 $3,192 · 2025 $4,620
Food & beverage: $4,440Education: $180
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 16 | $515 |
| ABBVIE INC. | 28 | $513 |
| Organon LLC | 17 | $474 |
| LEO Pharma Inc. | 30 | $464 |
| Janssen Biotech, Inc. | 17 | $456 |
| Galderma Laboratories, L.P. | 10 | $444 |
| Amgen Inc. | 14 | $304 |
| GENZYME CORPORATION | 11 | $249 |
| Lilly USA, LLC | 8 | $204 |
| Regeneron Healthcare Solutions, Inc. | 7 | $181 |
Products named: OPZELURA, DUPIXENT, TREMFYA, NEMLUVIO, VTAMA, SKYRIZI, OTEZLA, ADBRY.
Industry payments across VA — which companies pay providers there.
